Hematology

Incident conditions that may be attributable to COVID-19 are common among adult COVID-19 survivors, according to research published in the May 24 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Lara Bull-Otterson, Ph.D., from the CDC COVID-19 Emergency Response Team, and colleagues used electronic health record data...

Recommended erythropoietin-stimulating agent dosing changes for anemia care in adults undergoing hemodialysis led to lower erythropoietin-stimulating agent use and lower hemoglobin levels, according to a study published in the Clinical Journal of the American Society of Nephrology. Haesuk Park, Ph.D., from the University of Florida in Gainesville, and colleagues examined anemia care and clinical outcomes...

Sickle cell disease (SCD) imposes a considerable burden in terms of overall and out-of-pocket medical costs, with the burden of costs peaking in young adulthood, according to a study published in Blood Advances. Kate M. Johnson, Ph.D., from the University of Washington in Seattle, and colleagues estimated the total health care and out-of-pocket costs attributable...

Proposed changes to voluntary federal guidelines for prescribing opioid painkillers emphasize that doctors should first try other treatments for acute, subacute, and chronic pain. The non-opioid treatment options suggested by the U.S. Centers for Disease Control and Prevention include prescription medications like gabapentin and over-the-counter painkillers like ibuprofen (Advil, Motrin), as well as physical therapy, massage, and...

As one of the most commonly inherited disorders, sickle cell disease can warrant the need for specialized treatment plans. Especially when it comes to pain, different factors can arise and impact the daily lives of those with sickle cell disease. Therefore, there is a need for individualized care plans when treating acute pain crises from...

Pain, along with swelling and fatigue, is one of the cornerstone symptoms of sickle cell disease. Children with sickle cell disease may often experience painful vaso-occlusive episodes, which require appropriate pain management. In most cases, adequate pain management consists of rehydration, rest, and analgesics. But where do opioids fit into this treatment strategy? Common analgesics...

Barriers to proper treatment for sickle cell disease (SCD) depend not only on individual patient factors. Other factors involving healthcare provider knowledge on treating SCD and expertise can also hinder access to appropriate care. SCD is a rare disease that can lead to acute and chronic complications in patients. For this reason, optimal care is...

We know sickle cell disease (SCD) is most prevalent in people of African descent. However, a limited number of studies have evaluated whether sex-based differences occur with SCD. These studies have found that females with SCD are more likely to outlive males with SCD. One case series found that a handful of women with SCD...

Of the over 100,000 people in the U.S. with sickle cell disease (SCD), many face barriers to care in the forms of racism, low income, and lack of access to treatment through publically insured programs. As a result, this population can often find themselves cornered into what feels like a healthcare system that does not...